Type IIa hyperlipidaemia is a genetic condition where the body struggles to remove “bad” cholesterol from the blood, leading to dangerously high levels that can threaten the heart and arteries from a young age.

Understanding Type IIa Hyperlipidaemia

Type IIa hyperlipidaemia, also known as familial hypercholesterolemia, is a serious inherited disorder that affects how the body processes fats in the blood. People with this condition have extremely high levels of low-density lipoprotein cholesterol (LDL-C), which is often called “bad cholesterol” because it can build up in the walls of arteries. This buildup happens because the body either lacks or has faulty receptors that normally remove LDL cholesterol from the bloodstream.^[1]

The condition is passed down through families in a pattern called autosomal dominant inheritance. This means that if one parent has the condition, each child has about a 50% chance of inheriting it. The high cholesterol levels are present from birth and persist throughout life, making early detection and treatment crucial to prevent serious heart problems.^[4]

Unlike high cholesterol that develops from poor diet or lifestyle choices, Type IIa hyperlipidaemia is caused by genetic mutations. The most common type involves changes in the LDL receptor gene, which accounts for 80% to 90% of cases. These mutations prevent the body from clearing cholesterol properly, even when a person eats a healthy diet and exercises regularly.^[5]

How Common is This Condition?

Type IIa hyperlipidaemia is surprisingly common for a genetic disorder. The most frequent form, called heterozygous familial hypercholesterolemia, affects approximately one in every 300 people worldwide. This makes it one of the most common inherited conditions in humans.^[4]

A more severe form called homozygous familial hypercholesterolemia is much rarer, affecting about one in 160,000 to 500,000 people. Individuals with this form inherit the faulty gene from both parents and experience much more severe symptoms that can appear even in childhood.^[4]

Certain populations have higher rates of this condition due to their genetic background. Dutch Afrikaners, French Canadians, Ashkenazi Jews, Christian Lebanese, and some Tunisian groups show increased frequency of familial hypercholesterolemia. In these communities, the condition may be more common because specific gene mutations have been passed down through generations.^[4]

People with Type IIa hyperlipidaemia are at much greater risk for heart disease compared to the general population. They are 18 times more likely to develop arteriosclerotic cardiovascular disease (hardening of the arteries) and 21 times more likely to experience early-onset heart disease. These stark numbers highlight why recognizing and treating this condition early is so important.^[4]

What Causes Type IIa Hyperlipidaemia?

The root cause of Type IIa hyperlipidaemia lies in genetic mutations that disrupt the body’s normal cholesterol-clearing process. Three main genes can be affected, each playing a critical role in how cholesterol moves through the bloodstream.^[5]

The most common culprit is the LDLR gene, which provides instructions for making LDL receptors. These receptors sit on the surface of liver cells and act like docking stations that grab LDL cholesterol particles from the blood and pull them inside the liver for processing. When the LDLR gene has a mutation, these receptors either don’t work properly or aren’t made at all. Without functioning receptors, LDL cholesterol stays in the bloodstream, reaching dangerous levels. More than 1,600 different mutations in this gene have been identified.^[5]

Another gene involved is APOB, which makes a protein called apolipoprotein B-100. This protein sits on the surface of LDL cholesterol particles and acts like a key that fits into the LDL receptor lock. When the APOB gene is mutated, the protein doesn’t fit properly, so LDL particles can’t bind to receptors even when the receptors are working normally. This leads to poor removal of cholesterol from the blood.^[4]

The third gene is PCSK9, which makes a protein that regulates how long LDL receptors survive on cell surfaces. When mutated, this gene can cause receptors to break down too quickly, leaving fewer available to clear cholesterol from the blood. These mutations result in what’s called a “gain of function” problem, where the PCSK9 protein becomes too active in destroying receptors.^[4]

People can inherit these mutations in different ways. Those who inherit one mutated gene copy (heterozygous) typically have LDL cholesterol levels above 190 mg/dL in adults or above 160 mg/dL in children. Those who inherit two mutated copies (homozygous), one from each parent, can have LDL cholesterol levels exceeding 500 mg/dL and face severe complications even in childhood.^[11]

It’s worth noting that about 30% to 50% of people with symptoms of familial hypercholesterolemia don’t have a detectable mutation in any of these three genes. This suggests there may be other genetic factors involved that scientists haven’t yet identified.^[4]

Who is at Risk?

The primary risk factor for Type IIa hyperlipidaemia is having a parent with the condition. Because it follows an autosomal dominant inheritance pattern, children of affected parents have a 50% chance of inheriting the faulty gene. This means that a detailed family history is one of the most important tools for identifying people at risk.^[4]

Anyone with a family history of high cholesterol that doesn’t respond well to diet and lifestyle changes should be evaluated. Similarly, families where heart attacks, strokes, or heart disease occurred at young ages—before 55 in men or 65 in women—should raise suspicion for familial hypercholesterolemia.^[1]

Certain ethnic and geographic populations carry higher risk due to founder effects, where specific mutations became common in isolated communities. If you belong to one of these groups—such as Dutch Afrikaners, French Canadians, Ashkenazi Jews, Christian Lebanese, or certain Tunisian populations—your risk is elevated even without a known family history.^[4]

Children born to two parents with heterozygous familial hypercholesterolemia face the highest risk. These children can inherit the faulty gene from both parents, resulting in homozygous familial hypercholesterolemia. With less than 2% of normal LDL receptor activity, they experience extremely high cholesterol levels from birth and can develop heart disease even before adolescence.^[4]

Recognizing the Signs and Symptoms

One of the most challenging aspects of Type IIa hyperlipidaemia is that high cholesterol levels alone don’t cause noticeable symptoms. Many people feel perfectly healthy while dangerously high levels of cholesterol are quietly damaging their arteries. This is why the condition often goes undetected until serious complications occur.^[1]

However, people with very high cholesterol levels may develop visible signs that can alert doctors to the diagnosis. Xanthomas are painless, yellowish deposits of cholesterol that accumulate in tendons, most commonly in the Achilles tendons at the back of the ankle or in tendons of the hands. These lumps are caused by cholesterol building up in tissues and tend to worsen with age as cholesterol levels remain elevated.^[1]

Another visible sign is xanthelasmas, which are soft, yellowish, waxy deposits that appear on the eyelids or around the eyes. While these can occur in people without familial hypercholesterolemia, their presence, especially in younger individuals, should prompt cholesterol testing.^[1]

Some people develop corneal arcus, a white, gray, or blue opaque ring that forms around the colored part of the eye (the iris). This happens when cholesterol deposits in the cornea. While corneal arcus is common in elderly people, its appearance before age 45 is unusual and can indicate familial hypercholesterolemia.^[1]

The most serious symptoms occur when cholesterol buildup leads to atherosclerosis—hardening and narrowing of the arteries. This can cause chest pain (angina) when arteries supplying the heart become blocked, or leg pain when walking (claudication) if leg arteries are affected. In severe cases, the first symptom may be a heart attack or stroke, which is why early detection through screening is so crucial.^[1]

Children with homozygous familial hypercholesterolemia may develop symptoms extremely early. These can include xanthomas appearing before age 10, heart valve problems, and signs of heart disease even in childhood. Some develop calcification of the aortic valve, which can lead to heart failure if not treated.^[1]

Preventing Complications

While you cannot prevent Type IIa hyperlipidaemia itself—since it’s an inherited genetic condition—you can take important steps to prevent the heart disease complications that make this condition dangerous. Prevention focuses on identifying the condition early and managing cholesterol levels aggressively throughout life.^[1]

Early screening is the cornerstone of prevention. The National Heart, Lung, and Blood Institute recommends that children receive their first cholesterol screening between ages 9 and 11, with repeat testing every five years. Children from families with a history of early heart disease or familial hypercholesterolemia may need even earlier testing.^[11]

When one family member is diagnosed with familial hypercholesterolemia, it’s critical that all first-degree relatives—parents, siblings, and children—get tested. This cascade screening approach helps identify other family members who have inherited the condition before they develop symptoms or complications.^[5]

Even though the high cholesterol in Type IIa hyperlipidaemia is genetic, lifestyle modifications still play an important supporting role in management. A heart-healthy diet low in saturated fats and trans fats can help optimize cholesterol levels. While diet alone won’t bring cholesterol to safe levels in people with familial hypercholesterolemia, it works together with medication to provide better control.^[16]

Regular physical activity is another key prevention strategy. Exercise helps maintain healthy weight, improves blood vessel function, and can modestly improve cholesterol levels. Adults should aim for at least 150 minutes of moderate-intensity exercise per week, while children and teenagers should get at least 60 minutes of activity most days.^[16]

Avoiding smoking is absolutely essential. Smoking damages blood vessels and lowers HDL (good) cholesterol, compounding the already elevated risk of heart disease in people with familial hypercholesterolemia. If you smoke, quitting is one of the most important things you can do to protect your heart.^[16]

Maintaining a healthy weight helps reduce strain on the heart and can improve cholesterol levels. Being overweight tends to lower HDL cholesterol and raise LDL and triglyceride levels, making cholesterol management more difficult.^[16]

How the Body Changes in Type IIa Hyperlipidaemia

Understanding what happens inside the body when someone has Type IIa hyperlipidaemia helps explain why this condition is so dangerous. The problems begin at the cellular level with how the liver handles cholesterol particles circulating in the blood.^[5]

In healthy individuals, LDL cholesterol particles travel through the bloodstream carrying cholesterol to cells that need it. On the surface of liver cells are LDL receptors that recognize and bind to these particles. Once bound, the receptors pull the LDL particles inside the cell where the cholesterol is broken down and either used to build cell structures or converted to other substances. This process acts like a recycling system that keeps blood cholesterol at safe levels.^[6]

In Type IIa hyperlipidaemia, this recycling system fails. When LDL receptors are defective or absent, LDL particles continue circulating in the blood because they have nowhere to dock. The liver keeps producing LDL cholesterol as part of normal metabolism, but without working receptors to clear it, levels rise higher and higher. People with very few functioning receptors can have LDL levels three to five times higher than normal.^[6]

As LDL cholesterol accumulates in the bloodstream, some of it begins penetrating the walls of arteries. Inside the artery wall, LDL particles can become oxidized—damaged by chemical reactions with oxygen. The body’s immune system recognizes these oxidized LDL particles as foreign invaders and sends white blood cells called macrophages to engulf them. These macrophages become engorged with cholesterol and transform into “foam cells” that lodge in the artery wall.^[9]

Over time, clusters of foam cells combine with other inflammatory cells, calcium deposits, and scar tissue to form atherosclerotic plaques. These plaques are like bumps growing on the inside of artery walls, making the blood vessels narrower and less flexible. As arteries narrow, blood flow becomes restricted, depriving tissues of oxygen and nutrients. If a plaque ruptures, it can trigger blood clot formation that completely blocks the artery, causing a heart attack or stroke.^[9]

The severity of this process depends partly on how much LDL receptor activity remains. People classified as “receptor-negative” have less than 2% of normal receptor activity and experience the most severe cholesterol elevations and earliest onset of heart disease. Those who are “receptor-defective” retain 2% to 5% of normal activity and typically have slightly less severe disease, though still serious.^[4]

Beyond the arteries, chronically high cholesterol levels affect other tissues. Cholesterol deposits in tendons create xanthomas, while deposits around the eye lead to xanthelasmas and corneal arcus. In severe cases, cholesterol can accumulate in the heart valves, particularly the aortic valve, causing it to stiffen and not function properly. This can lead to heart failure even in young people.^[1]

The earlier these processes begin, the more damage accumulates over time. This is why people who inherit the condition from both parents (homozygous) and have almost no LDL receptor activity can develop severe atherosclerosis in childhood, sometimes requiring heart surgery before they’re even teenagers. Those with one mutated gene (heterozygous) typically develop problems in their 30s, 40s, or 50s—still much younger than the general population.^[1]